Medical Devices Singapore

Singapore Single-Use Endoscopes Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Singapore Single-Use Endoscopes Market Industry Trends and Forecast to 2034: Segmented by (Type, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $3.6 Mn Placeholder estimate
Estimate 2025 $4.1 Mn 0.1% of the global market
Projected 2034 $15.3 Mn 268.7% Adds $11.1 Mn over 9 forecast years
CAGR 2025–2034 15.6% Faster than 86% of 173 Medical Devices markets here
Key players 5
  • Singapore is 0.13% of the global market.
  • In APAC, the largest is China at $277.1 Mn.
  • Fastest growing: India at 17.6% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$11.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Single-Use Endoscopes Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $3.6 Mn — —
2025 (base) $4.1 Mn +$0.6 Mn —
2026 (forecast) $4.8 Mn +$0.6 Mn +15.6%
2027 (forecast) $5.5 Mn +$0.7 Mn +33.6%
2028 (forecast) $6.4 Mn +$0.9 Mn +54.5%
2029 (forecast) $7.4 Mn +$1.0 Mn +78.6%
2030 (forecast) $8.6 Mn +$1.2 Mn +106.4%
2031 (forecast) $9.9 Mn +$1.3 Mn +138.6%
2032 (forecast) $11.4 Mn +$1.5 Mn +175.9%
2033 (forecast) $13.2 Mn +$1.8 Mn +218.9%
2034 (forecast) $15.3 Mn +$2.1 Mn +268.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Singapore Single-Use Endoscopes Market Analysis at a glance
Market size, 2025$4.1 Mn placeholder estimate
Forecast, 2034$15.3 Mn placeholder estimate
Growth (CAGR), 2025–203415.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, setting and end user (see all)
Key playersAmbu A/S, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Pentax Medical (see all)
Regulator in SingaporeHSASource: Health Sciences Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Single-Use Endoscopes Market Analysis Executive Summary

Single-use endoscopes are thrown away after one patient, removing the risk of infection from poorly cleaned scopes.

Key segments of the single-Use Endoscopes market include type (Bronchoscopes, Ureteroscopes and Duodenoscopes) and setting (Hospitals, Ambulatory Surgery Centers and ICUs).

Bar chart: Singapore Single-Use Endoscopes market size, 2024–2034, placeholder estimates. $3.6 Mn in 2024, $4.1 Mn in 2025 and $15.3 Mn in 2034, 15.6% CAGR.
Singapore Single-Use Endoscopes market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Single-Use Endoscopes Market Dynamics

Market Growth Drivers

Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the single-Use Endoscopes market.

Opportunity

Smaller and cheaper systems, outpatient surgery centres and use in emerging markets give the single-Use Endoscopes market room to grow.

Market Restraints

High purchase and maintenance costs, training needs and limited proof of better outcomes for some procedures hold back the single-Use Endoscopes market.

Competitive Landscape for Single-Use Endoscopes Market in Singapore

The single-Use Endoscopes market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Single-Use Endoscopes Market in Singapore

Single-Use Endoscopes in Singapore: rules and payment

Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.⁠[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[2]

[1] Health Sciences Authority. Checked 14 Nov 2026.

[2] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how single-Use Endoscopes products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Single-Use Endoscopes right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Single-Use Endoscopes in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Single-Use Endoscopes market in Singapore?
Placeholder estimate: about $4.1 Mn in 2025, rising to about $15.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Single-Use Endoscopes market in Singapore growing?
Placeholder estimate: about 15.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Single-Use Endoscopes market report cover?
The report splits the market by type (Bronchoscopes, Ureteroscopes, Duodenoscopes, Cystoscopes), setting (Hospitals, Ambulatory Surgery Centers, ICUs) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Single-Use Endoscopes market?
Key players include Ambu A/S, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG and Pentax Medical.
What is driving the Single-Use Endoscopes market?
Demand for less invasive surgery, shorter hospital stays, surgeon shortages and improvements in robotics, imaging and AI are driving the single-Use Endoscopes market.
Who regulates Single-Use Endoscopes in Singapore?
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices. Source: Health Sciences Authority. Checked 14 Nov 2026.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on Single-Use Endoscopes?
PubMed lists 34 papers on Single-Use Endoscopes added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Singapore

See all

Related on surgery

See the topic